239 related articles for article (PubMed ID: 33616717)
1. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.
Gheytanchi E; Saeednejad Zanjani L; Ghods R; Abolhasani M; Shahin M; Vafaei S; Naseri M; Fattahi F; Madjd Z
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1631-1646. PubMed ID: 33616717
[TBL] [Abstract][Full Text] [Related]
2. Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis.
Fattahi F; Saeednejad Zanjani L; Vafaei S; Habibi Shams Z; Kiani J; Naseri M; Gheytanchi E; Madjd Z
Diagn Pathol; 2021 Mar; 16(1):26. PubMed ID: 33752711
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of tumor susceptibility gene 101 in hepatocellular carcinoma tissues].
Gu RJ; Wang SC; Sun G; Zhuang BW; Liu DL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):738-40. PubMed ID: 22768867
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
[TBL] [Abstract][Full Text] [Related]
6. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
[TBL] [Abstract][Full Text] [Related]
7. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Wang L; Lin D; Fu Y; Lai M
Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
[TBL] [Abstract][Full Text] [Related]
8. High expression level and nuclear localization of Sam68 are associated with progression and poor prognosis in colorectal cancer.
Liao WT; Liu JL; Wang ZG; Cui YM; Shi L; Li TT; Zhao XH; Chen XT; Ding YQ; Song LB
BMC Gastroenterol; 2013 Aug; 13():126. PubMed ID: 23937454
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
10. Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH.
Buhmeida A; Assidi M; Al-Maghrabi J; Dallol A; Sibiany A; Al-Ahwal M; Chaudhary A; Abuzenadah A; Al-Qahtani M
Cancer Invest; 2018 Feb; 36(2):129-140. PubMed ID: 29504811
[TBL] [Abstract][Full Text] [Related]
11. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
[TBL] [Abstract][Full Text] [Related]
12. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
13. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.
Gao XH; Liu QZ; Chang W; Xu XD; Du Y; Han Y; Liu Y; Yu ZQ; Zuo ZG; Xing JJ; Cao G; Fu CG
Cancer; 2013 Jun; 119(12):2212-22. PubMed ID: 23576061
[TBL] [Abstract][Full Text] [Related]
14. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631
[TBL] [Abstract][Full Text] [Related]
15. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
16. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
Xiao S; Liu L; Lu X; Long J; Zhou X; Fang M
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1465-74. PubMed ID: 25716692
[TBL] [Abstract][Full Text] [Related]
18. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Yang W; Wang Y; Wang W; Chen Z; Bai G
Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
[TBL] [Abstract][Full Text] [Related]
19. Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
Bae GE; DO SI; Kim K; Park JH; Cho S; Kim HS
Anticancer Res; 2019 Feb; 39(2):663-670. PubMed ID: 30711943
[TBL] [Abstract][Full Text] [Related]
20. POM121 overexpression is related to a poor prognosis in colorectal cancer.
Wang T; Sun H; Bao Y; En R; Tian Y; Zhao W; Jia L
Expert Rev Mol Diagn; 2020 Mar; 20(3):345-353. PubMed ID: 31858845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
